RT Journal Article
SR Electronic
T1 Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001403
DO 10.1136/jitc-2020-001403
VO 8
IS 2
A1 Cortellini, Alessio
A1 Ricciuti, Biagio
A1 Tiseo, Marcello
A1 Bria, Emilio
A1 Banna, Giuseppe L
A1 Aerts, Joachim GJV
A1 Barbieri, Fausto
A1 Giusti, Raffaele
A1 Cortinovis, Diego L
A1 Migliorino, Maria R
A1 Catino, Annamaria
A1 Passiglia, Francesco
A1 Torniai, Mariangela
A1 Morabito, Alessandro
A1 Genova, Carlo
A1 Mazzoni, Francesca
A1 Di Noia, Vincenzo
A1 Signorelli, Diego
A1 Gelibter, Alain
A1 Occhipinti, Mario Alberto
A1 Rastelli, Francesca
A1 Chiari, Rita
A1 Rocco, Danilo
A1 Inno, Alessandro
A1 De Tursi, Michele
A1 Di Marino, Pietro
A1 Mansueto, Giovanni
A1 Zoratto, Federica
A1 Grossi, Francesco
A1 Filetti, Marco
A1 Pizzutilo, Pamela
A1 Russano, Marco
A1 Citarella, Fabrizio
A1 Cantini, Luca
A1 Targato, Giada
A1 Nigro, Olga
A1 Ferrara, Miriam G
A1 Buti, Sebastiano
A1 Scodes, Simona
A1 Landi, Lorenza
A1 Guaitoli, Giorgia
A1 Della Gravara, Luigi
A1 Tabbò, Fabrizio
A1 Ricciardi, Serena
A1 De Toma, Alessandro
A1 Friedlaender, Alex
A1 Petrelli, Fausto
A1 Addeo, Alfredo
A1 Porzio, Giampiero
A1 Ficorella, Corrado
YR 2020
UL http://jitc.bmj.com/content/8/2/e001403.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.